Almeida AM - Search Results

1

Cell-type-specific transcriptional regulation of PIGM underpins the divergent hematologic phenotype in inherited GPl deficiency.

Costa JR, Caputo VS, Makarona K, Layton DM, Roberts IA, Almeida AM, Karadimitris A. Costa JR, et al. Among authors: almeida am. Blood. 2014 Nov 13;124(20):3151-4. doi: 10.1182/blood-2014-09-598813. Epub 2014 Oct 7. Blood. 2014. PMID: 25293775 Free PMC article.

2

Hypomorphic promoter mutation in PIGM causes inherited glycosylphosphatidylinositol deficiency.

Almeida AM, Murakami Y, Layton DM, Hillmen P, Sellick GS, Maeda Y, Richards S, Patterson S, Kotsianidis I, Mollica L, Crawford DH, Baker A, Ferguson M, Roberts I, Houlston R, Kinoshita T, Karadimitris A. Almeida AM, et al. Nat Med. 2006 Jul;12(7):846-51. doi: 10.1038/nm1410. Epub 2006 Jun 11. Nat Med. 2006. PMID: 16767100

3

Targeted therapy for inherited GPI deficiency.

Almeida AM, Murakami Y, Baker A, Maeda Y, Roberts IA, Kinoshita T, Layton DM, Karadimitris A. Almeida AM, et al. N Engl J Med. 2007 Apr 19;356(16):1641-7. doi: 10.1056/NEJMoa063369. N Engl J Med. 2007. PMID: 17442906 Free article.

4

Inherited glycosylphosphatidyl inositol deficiency: a treatable CDG.

Almeida A, Layton M, Karadimitris A. Almeida A, et al. Biochim Biophys Acta. 2009 Sep;1792(9):874-80. doi: 10.1016/j.bbadis.2008.12.010. Epub 2009 Jan 9. Biochim Biophys Acta. 2009. PMID: 19168132 Free article. Review.

5

Regulation of hematopoiesis in vitro and in vivo by invariant NKT cells.

Kotsianidis I, Silk JD, Spanoudakis E, Patterson S, Almeida A, Schmidt RR, Tsatalas C, Bourikas G, Cerundolo V, Roberts IA, Karadimitris A. Kotsianidis I, et al. Blood. 2006 Apr 15;107(8):3138-44. doi: 10.1182/blood-2005-07-2804. Epub 2005 Dec 22. Blood. 2006. PMID: 16373666 Free article.

6

Bone involvement in sickle cell disease.

Almeida A, Roberts I. Almeida A, et al. Br J Haematol. 2005 May;129(4):482-90. doi: 10.1111/j.1365-2141.2005.05476.x. Br J Haematol. 2005. PMID: 15877730 Free article. Review.

7

Human invariant NKT cells are required for effective in vitro alloresponses.

Patterson S, Kotsianidis I, Almeida A, Politou M, Rahemtulla A, Matthew B, Schmidt RR, Cerundolo V, Roberts IA, Karadimitris A. Patterson S, et al. J Immunol. 2005 Oct 15;175(8):5087-94. doi: 10.4049/jimmunol.175.8.5087. J Immunol. 2005. PMID: 16210612

8

Therapeutic challenges in childhood sickle cell disease. Part 2: a problem-orientated approach.

Amrolia PJ, Almeida A, Davies SC, Roberts IA. Amrolia PJ, et al. Br J Haematol. 2003 Mar;120(5):737-43. doi: 10.1046/j.1365-2141.2003.04144.x. Br J Haematol. 2003. PMID: 12614203 Free article. Review. No abstract available.

9

Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options.

Amrolia PJ, Almeida A, Halsey C, Roberts IA, Davies SC. Amrolia PJ, et al. Br J Haematol. 2003 Mar;120(5):725-36. doi: 10.1046/j.1365-2141.2003.04143.x. Br J Haematol. 2003. PMID: 12614202 Free article. Review. No abstract available.

10

Fludarabine-based stem cell transplantation protocol for Fanconi's anaemia in myelodysplastic transformation.

McCloy M, Almeida A, Daly P, Vulliamy T, Roberts IA, Dokal I. McCloy M, et al. Br J Haematol. 2001 Feb;112(2):427-9. doi: 10.1046/j.1365-2141.2001.02585.x. Br J Haematol. 2001. PMID: 11167843 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

652 results

Search Page

Filters